Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Supporting your high street Find out how »
Pharma M&A versus alliances and its underlying value drivers : Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective, Hardback Book

Pharma M&A versus alliances and its underlying value drivers : Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective Hardback

Part of the Corporate Finance and Governance series

Hardback

Out of stock

Description

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012.

Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value.

But what are the underlying value drivers which make a deal a success or a failure story?

The author derives significant innovative determinants of success for both strategies.

Information

Save 3%

£50.40

£48.85

Out of stock
Add to Basket
Sign in to add to wishlist
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Corporate Finance and Governance series  |  View all

Value Creation Within the Construction...

£32.85

£31.79

Add to Basket

Directors’ Dealings and Insider Trading...

£59.20

£56.95

Add to Basket

Underpricing, Long-Run Performance, and...

£40.75

£37.49

Add to Basket

Return Patterns of German Open-End Real...

£36.75

£34.59

Add to Basket